Page 10 - Fortis Healthcare

Health care industry needs self-regulation: Fortis Healthcare CEO

Bhavdeep Singh says there is trust deficit everywhere and steps need to be taken

Supreme Court refuses permission to sell shares in Fortis Healthcare

Shares of Fortis Healthcare closed 5.44 percent lower to trade at Rs 146 per share on Thursday after the Supreme Court refused to afford any relief to promoters Malvinder Singh and Shivinder Sing and lender banks of the company to part with their encumbered shareholdings. Encumbered assets are those shares that are pledged or offered as collateral to a lender.Directing the applicants to maintain status quo on shareholding, the apex court clarified that its August 11 order not to sell their stock, included both encumbered and unencumbered assets and extended to even lender banks and shares pledged to them by the company. Japanese pharmaceutical giant Daiichi Sankyo, had earlier in August moved the Supreme Court to block the sale of Fortis shares by promoters and other entities in order to preserve assets in the company to realise a Rs 2,562 crore Singapore arbitration award against the Singh brothers in favour of the foreign company. On Thursday, Axis Bank and Yes Bank - which also ...

Fortis Healthcare tanks 6% as SC bars promoters from selling pledged shares

SC reaffirmed that Singh brothers cannot sell both encumbered and non-encumbered assets

Why big investors, brokerages like Fortis Healthcare

The Fortis Healthcare stock was up 8 per cent after buy ratings from brokerages and on news that Rakesh Jhunjhunwala picked up a stake in the company on Tuesday. For a company whose stock has taken a beating - down almost a third per cent in about three months, due to issues at the promoter group that have little direct impact for Fortis, these latest developments are a welcome. So, why this positive stance on Fortis?Goldman Sachs, which has a buy rating on the company, believes the mature hospitals and better occupancies will lead to margin expansion to the tune of 280 basis points during the FY18-20 period. Flagship hospitals will drive revenues, which is pegged to grow at 11 per cent annually over the same period. Other analysts expect its revenues to grow by about 10 per cent annually led by higher volumes as well as better product (specialty) mix. About 80 per cent of the company's owned beds are five years old, which coupled with occupancies in excess of 60 per cent translates ..

Fortis Healthcare gains 6% after Rekha Jhunjhunwala buys stake

On August 22, Rekha Jhunjhunwala bought 4.5 million shares of Fortis at Rs 134.65 per share on NSE

Rekha Jhunjhunwala buys 45 lakh shares in Fortis Healthcare

Rekha Jhunjhunwala, wife of veteran investor Rakesh Jhunjhunwala, on Tuesday purchased 45 lakh shares of Fortis Healthcare at Rs 134.6 apiece totalling Rs 61 crore through an open market transaction, data put up on National Stock Exchange of India showed.The identity of the seller was not known. Shares of the company fell 12 per cent in early morning trade to Rs 125.5 before recovering to close at Rs 144.4 on the NSE, up 0.48 per cent from the previous day's close.In February 2015, Rakesh Junjhunwala had bought 34.8 lakh shares of Fortis Healthcare at Rs 119.35 per share, for about Rs 41 crore via an open market deal.On August 14, Fortis Healthcare had informed the stock exchanges that Fortis Healthcare Holdings, the promoter of the company, sold 5.46 million, or 1.05 per cent, equity shares on August 10, through an off-market transaction. Earlier, on July 18, Fortis Healthcare Holdings had sold 13.5 million or 2.6 per cent stake of Fortis Healthcare for Rs 203 crore through open ...

Promoters pledge 2.6 mn more shares in Fortis Healthcare

Rekha Jhunjhunwala acquires shares worth Rs 61 crore

Fortis Healthcare trims losses, stock down 1% after falling 13% intraday

A combined 19.15 million equity shares changed hands on NSE and BSE till 10:20 am.

Fortis Healthcare: Correction a good entry point

Steady growth and value unlocking potential are keeping analysts positive on the company

RBI allows foreign investors buy up to 74% stake in Fortis Healthcare

RBI had put Fortis Healthcare under the ban list last month with respect to foreign investment

Fortis shareholders approve hike in FII investment cap from 24% to 74%

Fortis Healthcare earlier got shareholders' nod to raise up to Rs 5,000 crore

Fortis Healthcare slips 15% as Malaysian firm denies stake buy report

The stock slipped 15% to Rs 168 on NSE on back of heavy volumes.

Not close to any deal with Fortis, says IHH

Fortis sources says deal is still on

Malaysia's IHH Healthcare dismisses report it's close to buying Fortis

The Malaysian healthcare major runs chain of hospitals in Asia, and Central and Eastern Europe

No decision yet on ways to raise up to Rs 5,000 cr: Fortis

The shares of Fortis Healthcare closed at Rs 197.80 per scrip on BSE

Fortis gets notice from Maharashtra FDA for two hospitals

Matter pertains to single-use devices that are used for angioplasty to remove blockages in arteries

Fortis Healthcare Q3 net profit at Rs 453.29 crore

Fortis Healthcare stock closed 5.25 per cent up at Rs 195.60 on BSE

Fortis Healthcare hits record high on heavy volumes

The stock hit a record high of Rs 205, outperformed the market by gaining 18% in past one month.

Fortis Healthcare stock awaiting a breakout

Beyond the near-term impact of demonetisation, margin expansion in both hospitals and diagnostic businesses will drive earnings

Fortis to add two hospitals through operations and management contracts

The hospitals, in Rajasthan, will be operational by March 2017